Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
propafenone betablockers,non-selective

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone betablockers,non-selective

increases exposure

Unknown Anecdotal
propafenone betablockers,selective

increases exposure

Unknown Study
propafenone labetalol

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone levobunolol

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone metoprolol

increases exposure

Unknown Study
propafenone nadolol

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone pindolol

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone relugolix

increases exposure

Unknown Theoretical
propafenone sotalol

increases risk of cardiovascularadverseeffects

Unknown Study
propafenone talazoparib

increases exposure

Unknown Theoretical
propafenone timolol

increases exposure

Unknown Anecdotal
propafenone tricyclicantidepressants

increases concentration

Unknown Theoretical
propiverine lomitapide

increases exposure

Unknown Theoretical
propofol theactivecomponentofsacituzumabgovitecan

increases exposure

Unknown Theoretical
propranolol rizatriptan

increases exposure

Unknown Study
propranolol triptans

increases exposure

Unknown Study
protonpumpinhibitors alpelisib

increases exposure

Unknown Theoretical
protonpumpinhibitors cannabidiol

increases exposure

Unknown Theoretical
protonpumpinhibitors cilostazol

increases exposure

Unknown Theoretical
protonpumpinhibitors ulipristalforemergencyhormonalcontraception

decreases efficacy

Unknown Theoretical
pyrimethamine antiepileptics

increases risk of haematologicaltoxicity

Unknown Study
pyrimethamine fosphenytoin

increases risk of haematologicaltoxicity

Unknown Study
pyrimethamine methotrexate

increases risk of adverseeffects

Unknown Theoretical
pyrimethamine pemetrexed

increases risk of adverseeffects

Unknown Theoretical
pyrimethamine phenobarbital

increases risk of haematologicaltoxicity

Unknown Theoretical
pyrimethamine phenytoin

increases risk of haematologicaltoxicity

Unknown Study
pyrimethamine primidone

increases risk of haematologicaltoxicity

Unknown Theoretical
quetiapine levodopa

decreases effects

Unknown Anecdotal
ranibizumab argatroban

increases risk of bleedingevents

Unknown Theoretical
ranibizumab bivalirudin

increases risk of bleedingevents

Unknown Theoretical
ranibizumab danaparoid

increases risk of bleedingevents

Unknown Theoretical
ranibizumab phenindione

increases risk of bleedingevents

Unknown Theoretical
ranibizumab thrombininhibitors

increases risk of bleedingevents

Unknown Theoretical
ranitidine lomitapide

increases exposure

Unknown Theoretical
ranolazine afatinib

increases exposure

Unknown Study
ranolazine aliskiren

increases exposure

Unknown Theoretical
ranolazine apixaban

increases exposure

Unknown Theoretical
ranolazine atorvastatin

increases exposure

Unknown Theoretical
ranolazine berotralstat

increases exposure

Unknown Study
ranolazine betablockers,non-selective

increases exposure

Unknown Study
ranolazine colchicine

increases exposure

Unknown Theoretical
ranolazine dabigatran

increases exposure

Unknown Theoretical
ranolazine digoxin

increases concentration

Unknown Study
ranolazine docetaxel

increases exposure

Unknown Theoretical
ranolazine edoxaban

increases exposure

Unknown Theoretical
ranolazine erlotinib

increases exposure

Unknown Theoretical
ranolazine gilteritinib

increases exposure

Unknown Theoretical
ranolazine larotrectinib

increases exposure

Unknown Theoretical
ranolazine lomitapide

increases exposure

Unknown Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.